Clinical Trial: 18F-FES PET/CT in the Treatment Planning, and Response Assessment of ER-Positive Breast Cancer

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07859046) titled '18F-FES PET/CT in the Treatment Planning, and Response Assessment of ER-Positive Breast Cancer' on Sept. 29.

Brief Summary: This study uses FES PET/CT imaging to evaluate estrogen receptor-positive breast cancer. FES PET/CT is a type of imaging that can show whether breast cancer cells have estrogen receptors. The purpose of this study is to see how well FES PET/CT can help doctors: (1) diagnose ER-positive breast cancer, (2) plan the best treatment, and (3) check how well treatment is working. Participants will undergo FES PET/CT scans as part of their regular cancer care or study procedures. The results may help improve how doctors...